Oncolys BioPharma
4588.TTSE GROWTHPharmaceutical
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 8
| SMBC Nikko Securities Inc. | 4.58% |
| Evo Fund | 4.31% |
| Gomi Daisuke | 3.91% |
| Morgan Stanley & Co. LLC | 1.29% |
| Morgan Stanley MUFG Securities Co., Ltd. | 0.87% |
| Morgan Stanley & Co. International plc | 0.61% |
| Sumitomo Mitsui Banking Corporation | 0.00% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 36
| Holder | Ratio | Change |
|---|---|---|
| Evo Fund2024-07-08 · amended | 4.43% | -1.01pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | no change |
| Evo Fund2024-07-08 · amended | 5.44% | -1.72pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | no change |
| Evo Fund2024-07-08 · amended | 7.16% | -1.32pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | no change |
| Evo Fund2024-07-08 · amended | 8.48% | -2.36pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | no change |
| Evo Fund2024-07-08 · amended | 10.84% | -1.38pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | no change |
| Evo Fund2024-07-08 · amended | 12.22% | -1.16pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | no change |
| Evo Fund2024-07-08 · amended | 13.38% | -1.96pp |
| Evolution Capital Management LLC2024-07-08 · amended | 0.00% | new |
| Evo Fund2024-07-08 · amended | 15.34% | new |
| SMBC Nikko Securities Inc.2024-02-22 | 4.43% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.